Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer.

A MigeotteV DufourA van MaanenM BerliereJ L CanonD TaylorFran Ois P Duhoux

Published in: BMC cancer (2021)

Unlike with conventional chemotherapy, the line of treatment in which T-DM1 is administered does not influence PFS in our cohort of patients with advanced HER2-positive breast cancer.

Keyphrases

positive breast cancer
free survival
metastatic breast cancer
squamous cell carcinoma
radiation therapy
combination therapy
metabolic syndrome
replacement therapy
skeletal muscle
weight loss
smoking cessation